← Leaderboards
Harry D Bear
Virginia Commonwealth University
$5,428,734
Attributed
$12,950,947
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–24$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,950,947 · 8
By mechanism
UG1$11,528,320 · 1
R01$1,045,928 · 1
P30$330,608 · 3
T32$45,443 · 1
M01$648 · 2
Top collaborators
- Khalid Matin6 shared
- Vanessa B Sheppard6 shared
- Andrew James Barnes5 shared
- Charles Edward Geyer4 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Gordon D Ginder$21,192,432
- Steven Grant$20,337,700
- John D Roberts$6,720,279
- Darlene H Brunzell$3,114,387
- Tamas S Gal$737,860
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchMissionProgramsMalignant NeoplasmsVirginiaClinical TrialsUniversitiesCancer CenterResearch PersonnelCancer CareCancer PatientCancer Clinical TrialEnrollmentCatchment AreaResourcesScienceProtocols DocumentationCancer TherapyMemberUnderserved PopulationAwardCollectionCommunitiesCommunity Clinical Oncology Program
Grant awards (29)
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$1,189,949
UG1 · FY2024 · CA
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$1,075,978
UG1 · FY2023 · CA
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$1,180,709
UG1 · FY2022 · CA
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$1,165,162
UG1 · FY2021 · CA
Early Phase Clinical Research Support$20,634
P30 · FY2021 · CA · contact PI
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$878,957
UG1 · FY2020 · CA
Protocol Review and Monitoring System$45,585
P30 · FY2020 · CA · contact PI
VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program$1,213,253
UG1 · FY2019 · CA
Protocol Review and Monitoring System$50,778
P30 · FY2019 · CA · contact PI
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program$1,196,666
UG1 · FY2018 · CA
Protocol Review and Monitoring System$50,710
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$12,845
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$11,991
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$5,070
P30 · FY2018 · CA · contact PI
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program$690,934
UG1 · FY2017 · CA
Protocol Review and Monitoring System$50,573
P30 · FY2017 · CA · contact PI
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program$951,712
UG1 · FY2016 · CA
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program$980,000
UG1 · FY2015 · CA · contact PI
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program$1,005,000
UG1 · FY2014 · CA
Expansion of Anti Tumor T Cells from Tumor Bearing Hosts$267,000
R01 · FY2004 · CA
Expansion of Anti Tumor T Cells from Tumor Bearing Hosts$267,000
R01 · FY2003 · CA
Expansion of Anti Tumor T Cells from Tumor Bearing Hosts$267,000
R01 · FY2002 · CA
CORE--HYBRIDOMA/CELL CULTURE/IMMUNE MONITORING$41,211
P30 · FY2002 · CA
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID TUMOR MALIGNANCIES$0
M01 · FY2001 · RR
EXPANSION OF ANTITUMOR T CELLS FROM TUMOR-BEARING HOSTS$244,928
R01 · FY2000 · CA
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$45,443
T32 · FY2000 · CA
CORE--HYBRIDOMA MONOCLONAL ANTIBODY$41,211
P30 · FY2000 · CA
PHASE I STUDY OF ADOPTIVE CELLULAR THERAPY OF SOLID TUMOR MALIGNANCIES$648
M01 · FY2000 · RR
ADOPTIVE CELLULAR THERAPY OF BREAST CANCER WITH HER2/NEU$0
M01 · FY2000 · RR